Bruker Corporation

Healthcare · Medical Devices

61.60$ +0.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Bruker Corporation (BRKR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 6,053 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BRKR
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	3,820	4,250	4,506	5,903	6,113	5,807	5,933	6,340	6,435	6,241	6,131	6,053
Current Assets	2,029	2,164	2,140	2,153	2,191	2,053	2,112	2,163	2,351	2,213	2,104	2,225
Cash	364	488	340	170	148	183	184	92	293	299	133	185
Cash & Short-Term Investments	364	488	340	170	148	183	184	92	293	299	133	185
Receivables	656	622	636	694	713	701	701	739	767	736	750	875
Inventory	916	968	1,061	1,176	1,220	1,068	1,117	1,218	1,197	1,095	1,122	1,120
Goodwill	561	583	752	1,444	1,475	1,507	1,533	1,649	1,550	1,548	1,573	1,430
Intangible Assets	292	331	449	1,024	1,027	913	902	970	919	900	902	868
Total Liabilities	2,575	2,837	3,056	4,078	4,270	3,992	4,082	4,473	3,943	3,731	3,628	3,634
Current Liabilities	1,072	1,202	1,183	1,305	1,322	1,281	1,345	1,347	1,268	1,279	1,355	1,205
Short-Term Debt	121	145	21	26	33	65	38	56	24	52	8.4	101
Accounts Payable	182	203	199	220	228	234	245	243	184	216	269	200
Long-Term Debt	1,099	1,160	1,357	2,132	2,265	2,062	2,076	2,380	1,984	1,853	1,663	1,815
Shareholders' Equity	1,209	1,377	1,415	1,789	1,807	1,781	1,817	1,804	2,432	2,457	2,449	2,400
Retained Earnings	–	2,324	2,367	2,367	2,401	2,407	2,416	2,416	2,352	2,362	2,358	2,288
Shares Outstanding	147	146	146	148	152	152	152	152	152	153	153	152

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings